TABLE 7.
Monocytes | RT | RC | SET | SEC | p between groups* | p between groups # | |||
---|---|---|---|---|---|---|---|---|---|
RT | RC | SET | SEC | ||||||
Classical | 30.73 (1.77) | 31.48 (2.17) | 34.10 (2.41) | 27.44 (2.11) | .158 | ||||
Intermediate | 53.11 (2.27) | 52.49 (2.50) | 51.45 (2.60) | 61.65 (2.11) | .020 | <.0001 | <.0001 | <.0001 | <.0001 |
Non-classical | 3.90 (.90) | 4.84 (1.21) | 4.41 (1.02) | 4.52 (.97) | .097 |
Data represent means (standard errors of means–SEM). Kruskal-Wallis test, *comparisons between monocyte groups (classical × intermediate × non-classical) and #comparisons between treatment arms. RT, Rosuvastatin + Ticagrelor; RC, Rosuvastatin + Clopidogrel; SET, Simvastatin + Ezetimibe + Ticagrelor; SEC, Simvastatin + Ezetimibe + Clopidogrel.